Biofrontera (BFRI) Research & Development (2023 - 2025)
Biofrontera's (BFRI) quarterly Research & Development came in at $787000.0 in Q4 2025, up 0.51% year-on-year from $783000.0 in Q4 2024, and down 7.85% quarter-over-quarter from $854000.0 in Q3 2025.
Biofrontera (BFRI) Research & Development (2023 - 2025) Analysis & Trends
Biofrontera's Research & Development history runs 3 years deep, the most recent figure standing at $787000.0 for Q4 2025.
- On a quarterly basis, Research & Development rose 0.51% year-over-year to $787000.0 in Q4 2025; TTM through Dec 2025 was $3.7 million, a 77.89% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, up 78.03% from the prior year.
- Research & Development declined to $787000.0 in Q4 2025 per BFRI's latest filing, from $854000.0 in the prior quarter.
- Across five years, Research & Development topped out at $1.2 million in Q1 2025 and bottomed at $11000.0 in Q2 2023.
- The 3-year median for Research & Development is $669000.0 (2024), against an average of $535000.0.
- Biggest YoY gain for Research & Development was 7000.0% in 2025; the steepest drop was 0.51% in 2025.
- Year by year, Research & Development stood at $33000.0 in 2023, then soared by 2272.73% to $783000.0 in 2024, then gained by 0.51% to $787000.0 in 2025.
- Per Business Quant, the three latest BFRI Research & Development figures stand at $787000.0 (Q4 2025), $854000.0 (Q3 2025), and $870000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 138.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 787,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 787,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 669,000.00 |
| Jun 30, 2024 | 621,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 11,000.00 |